Resumption of spontaneous ovulation · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
no estimate extracted
2016 participants
GRADE not reported
Clinician's assessment of improvement of hirsutism Ferriman‐Gallwey score Scale from: 0 to 36 · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
no estimate extracted
2016 participants
GRADE not reported
Improvement in acne severity · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
no estimate extracted
2016 participants
GRADE not reported
Improvement in testosterone level (nmol/L) after 6 months' treatment · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
no estimate extracted
2016 participants
GRADE not reported
Clinician's assessment of improvement of hirsutism Ferriman‐Gallwey score Scale from: 0 to 36 · women with polycystic ovary syndrome not actively trying to conceive
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
no estimate extracted
2016 participants
GRADE not reported
Improvement in acne severity · women with polycystic ovary syndrome not actively trying to conceive
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in testosterone level (nmol/L) after 6 months' treatment · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
Adverse effects · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
Mean pressure gradient (mmHg) Better indicated by lower scores. · patients with aortic valve stenosis
Statin showed no clear difference in mean pressure gradient (mmHg) Better indicated by lower scores. compared with placebo (low certainty).
1 finding from 1 review
Valve area (cm2) Better indicated by higher scores. · patients with aortic valve stenosis
Statin showed no clear difference in valve area (cm2) Better indicated by higher scores. compared with placebo (low certainty).
1 finding from 1 review
Aortic jet velocity (m/s) · patients with aortic valve stenosis
Statin showed no clear difference in aortic jet velocity (m/s) compared with placebo (low certainty).
1 finding from 1 review
Freedom from valve replacement · patients with aortic valve stenosis
Statin showed no clear difference in freedom from valve replacement compared with placebo (moderate certainty).
1 finding from 1 review
All cardiovascular death · patients with aortic valve stenosis
Statin showed no clear difference in death from cardiovascular cause compared with placebo (low certainty).
1 finding from 1 review
Hospitalisation for any reason · patients with aortic valve stenosis
It is very uncertain whether statin changes hospitalisation for any reason compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ Muscle pain · patients with aortic valve stenosis
Statin showed no clear difference in adverse events ‐ Muscle pain compared with placebo (moderate certainty).
1 finding from 1 review
Total VTE · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin probably leads to lower all cases of VTE compared with placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
1 finding from 1 review
Deep vein thrombosis · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
1 finding from 1 review
Any MI · 17,802 patients with low to normal levels of low density lipoprotein (LDL) cholesterol (< 130 mg/dL)
Statin probably leads to lower any MI compared with placebo (moderate certainty).
1 finding from 1 review